Bandingkan Harga & Kinerja Pulau Subur Tbk. (PTPS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pulau Subur Tbk. dan Organon Pharma Indonesia Tbk.: Pulau Subur Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 359,81 M, volume 24 jam 2,22 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pulau Subur Tbk. jauh lebih besar — sekitar 3,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PTPS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 359,81 M | 104,4 M |
Volume | 2,22 jt | — |
Lot | 22,22 rb | — |
Perputaran | 366,22 jt | — |
Harga Rata-rata | 164,84 | — |
Nilai Transaksi | 366,22 jt | — |
Harga Ekuilibrium Indikatif | 165 | — |
Volume Ekuilibrium Indikatif | 417 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pulau Subur Tbk.
PT Pulau Subur Tbk (the Company) was established based on Deed No. 1 of October 1, 1980 by Justin AR, S.H., notary in Palembang. The Company started its commercial operations in October 1980. PT Sekawan Kontrindo, is the parent entity of the Company. The ultimate shareholders of the Company is Mr. Abunawar.
Selengkapnya di halaman PTPS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
